MB
MPM Bioventures 2018, L.P. sold $617K of TRDA stock
MPM Bioventures 2018, L.P., 10% owner of Entrada Therapeutics, Inc. (TRDA), sold 86,482 shares of TRDA stock worth $617K, per an SEC Form 4 filed Sep 3, 2026.
It was an open-market sale.
The trade happened on Sep 1, 2026, 2 days before it was made public.
TRDA has moved -34.4% since the trade date, from $7.07 to $4.64 (Nov 19, 2026 close).
- Traded
- Sep 1, 2026
- Disclosed
- Sep 3, 2026
- Filing delay
- 2 days
- Price since
- -34.4%
- Role
- 10% owner
- Source
- SEC Form 4
More TRDA insider and Congress trades
- SellTRDA · MPM Bioventures 2018, L.P.$1.9MSep 9, 2026
- SellTRDA · MPM BioVentures 2014, L.P.$1.9MSep 9, 2026
- SellTRDA · MPM BioVentures 2014, L.P.$617KSep 3, 2026
- SellTRDA · MPM Bioventures 2018, L.P.$616KAug 31, 2026
- SellTRDA · MPM BioVentures 2014, L.P.$616KAug 31, 2026
- SellTRDA · MPM BioVentures 2014, L.P.$462KAug 27, 2026